SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-006462
Filing Date
2017-06-12
Accepted
2017-06-09 19:17:36
Documents
23
Period of Report
2017-06-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 24264
2 ex99-1.htm EX-99.1 20175
3 image_001.jpg GRAPHIC 74778
4 image_002.jpg GRAPHIC 117117
5 image_003.jpg GRAPHIC 42420
6 image_004.jpg GRAPHIC 67273
7 image_005.jpg GRAPHIC 36090
8 image_006.jpg GRAPHIC 48180
9 image_007.jpg GRAPHIC 70843
10 image_008.jpg GRAPHIC 70469
11 image_009.jpg GRAPHIC 55819
12 image_010.jpg GRAPHIC 34795
13 image_011.jpg GRAPHIC 34514
14 image_012.jpg GRAPHIC 36952
15 image_013.jpg GRAPHIC 45701
16 image_014.jpg GRAPHIC 43689
17 image_015.jpg GRAPHIC 39548
18 image_016.jpg GRAPHIC 53605
19 image_017.jpg GRAPHIC 51583
20 image_018.jpg GRAPHIC 59491
21 image_019.jpg GRAPHIC 52642
22 image_020.jpg GRAPHIC 46152
23 image_021.jpg GRAPHIC 18578
  Complete submission text file 0001493152-17-006462.txt   1563184
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54933 | Film No.: 17904158
SIC: 2834 Pharmaceutical Preparations